SBC Medical Group Holdings Incorporated (SBC)
Official siteINDUSTRIALS • CONSULTING SERVICES • NASDAQ
Market Cap: $755.92M
Last updated: Nov 17, 2026 at 11:06 AM ET
SBC Medical Group Holdings Incorporated (SBC) Stock Forecast
Analysts expect SBC Medical Group Holdings (SBC) to earn $0.46 per share in the fiscal year ending Dec 31, 2026, on revenue of $190.98M. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 33.3% |
| Buy | 2 | 66.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 17.4% and revenue estimates rise 10.1%.
- Fiscal year ending Dec 31, 2026
- $0.46
- EPS consensus, revenue $190.98M
- Fiscal year ending Dec 31, 2027
- $0.54
- EPS consensus, revenue $210.35M
- Next report
- Mar 25, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.46 | $0.42 to $0.48 | 4 | $190.98M | $182.51M to $197.85M | 5 |
| Dec 31, 2027 | $0.54 | $0.52 to $0.56 | 2 | $210.35M | $192.40M to $222.58M | 4 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.12 | $0.10 to $0.14 | 6 | $52.04M | $42.65M to $61.22M | 6 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 4 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 2 |
| Fiscal year ending Dec 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 2.1% from $0.47.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.46 | $0.46 | $0.46 | $0.46 | $0.47 | -1.1% |
| Fiscal year ending Dec 31, 2027 | $0.54 | $0.54 | $0.54 | $0.54 | $0.49 | +11.3% |
Frequently Asked Questions About SBC
What is the SBC stock forecast?
Consensus analyst estimates put SBC Medical Group Holdings's EPS at $0.46 for the fiscal year ending Dec 31, 2026, on revenue of $190.98M. The consensus rating from 3 analysts is Buy.
How do analysts rate SBC stock?
Of 3 analysts covering SBC Medical Group Holdings, 1 rates it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from SBC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.46, with estimates from $0.42 to $0.48 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.54, with estimates from $0.52 to $0.56 from 2 analysts.
What revenue do analysts expect from SBC Medical Group Holdings next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $190.98M, with estimates from $182.51M to $197.85M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $210.35M, with estimates from $192.40M to $222.58M.
How many analysts cover SBC?
3 analysts rate SBC Medical Group Holdings stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SBC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors